Search Results - "Khodadoust, M."

Inferring a causal relationship between ceramide levels and COVID-19 respiratory distress by Khodadoust, Mehran M.

“…A causal relationship between plasma ceramide concentration and respiratory distress symptoms in COVID-19 patients is inferred. In this study, plasma samples…”
Get full text

Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome by Torrey, H, Khodadoust, M, Tran, L, Baum, D, Defusco, A, Kim, Y H, Faustman, D L

“…Sézary syndrome (SS) is a rare form of cutaneous T-cell lymphoma often refractory to treatment. SS is defined as adenopathy, erythroderma with high numbers of…”
Get full text

Targeted killing of TNFR2-expressing tumor cells and T regs by TNFR2 antagonistic antibodies in advanced Sézary syndrome by Torrey, H, Khodadoust, M, Tran, L, Baum, D, Defusco, A, Kim, Y H, Faustman, D L

“…Sézary syndrome (SS) is a rare form of cutaneous T-cell lymphoma often refractory to treatment. SS is defined as adenopathy, erythroderma with high numbers of…”
Get full text

Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia by Khodadoust, M S, Luo, B, Medeiros, B C, Johnson, R C, Ewalt, M D, Schalkwyk, A S, Bangs, C D, Cherry, A M, Arai, S, Arber, D A, Zehnder, J L, Gotlib, J

Get full text

Long‐term outcomes with mogamulizumab alone or in combination with other therapies for the treatment of cutaneous t‐cell lymphoma by Bojanini, L., Herrera, M., Li, S., Xu, N., Ahmed, A. A., Khodadoust, M., Kim, Y. H.

Get full text

DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress by Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor-Vaknin, N., Moreno-Villanueva, M., Bürkle, A., Markovitz, D. M., Ferrando-May, E.

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Genomic abnormalities involving class I HLA are common in advanced cutaneous T‐cell lymphoma by Kwang, A. C, Duran, G. E., Li, S., Torres, A. N. Bastidas, Herrera, M., Wang, E. B., Kurtz, D. M., Kim, Y. H., Khodadoust, M. S.

Get full text

A PHASE II TRIAL OF REDUCED DOSE BRENTUXIMAB VEDOTIN FOR CUTANEOUS T‐CELL LYMPHOMAS by Khan, N., Noor, S., Geller, S., Khodadoust, M. S., Kheterpal, M., Hancock, H., Davey, T., Ryu, S., Perez, L., Lares, A., Ganesan, N., Sohail, S., Santarosa, A., Galasso, N., Kim, E., Myskowski, P., Kim, Y. H., Horwitz, S., Moskowitz, A.

Get full text

DETERMINANTS OF RESISTANCE TO ENGINEERED T‐CELL THERAPIES TARGETING CD19 IN LYMPHOMA by Sworder, B, Kurtz, D. M, Alig, S, Frank, M. J, Macauley, C. W, Garofalo, A, Shukla, N, Sahaf, B, Esfahani, M. S, Sheybani, N, Schroers-Martin, J, Liu, C. L, Olsen, M., Spiegel, J. Y, Oak, J, Jin, M. C, Beygi, S, Khodadoust, M. S, Natkunam, Y, Majzner, R, Mackall, C. L, Diehn, M, Miklos, D. M, Alizadeh, A. A

Get full text

THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ACTIVE AGAINST RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA WITH LOW RATES OF TRANSAMINITIS: FINAL RESULTS by Horwitz, S. M., Moskowitz, A. J., Mehta‐Shah, N., Jacobsen, E. D., Khodadoust, M. S., Ganesan, N., Drill, E., Hancock, H., Davey, T., Myskowski, P., Maccaro, C., Blouin, W., Schwieterman, J., Cathcart, E., Fang, S., Perez, L., Ryu, S., Galasso, N., Straus, D., Fisher, D. C., Kumar, A., Noy, A., Falchi, L., Dogan, A., Kim, Y. H., Weinstock, D.

Get full text

A PHASE 1/1B DOSE‐ESCALATION TRIAL EVALUATING CPI‐818, AN ORAL INTERLEUKIN‐2‐INDUCIBLE T‐CELL KINASE INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY T‐CELL LYMPHOMA by Mobasher, M., Miller, R., Janc, J., Kwei, L., Barker, C., Mohammady, A., Luciano, G., Radeski, D., Kim, Y., Khodadoust, M., Horwitz, S.

Get full text

A SELECTIVE AND COVALENT INHIBITOR OF ITK BLOCKS TCR SIGNALING, INHIBITS PROLIFERATION OF HUMAN SÉZARY CELLS IN VITRO, AND INDUCES TUMOR REGRESSION IN DOGS WITH T‐CELL LYMPHOMA by Buggy, J.J., Ng, P.P., Janc, J.W., Hotson, A., Hill, C.M., Thamm, D.H., Kim, Y.H., Khodadoust, M., Mobasher, M., Miller, R.A.

Get full text

LACUTAMAB IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES (MF): EFFICACY RESULTS ACCORDING TO UPDATED LYMPH NODE (LN) CLASSIFICATION IN THE TELLOMAK STUDY by Kim, Y. H., Bagot, M., Ortiz‐Romero, P. L., Zinzani, P. L., Beylot‐Barry, M., Dalle, S., Jacobsen, E., Combalia, A., Huen, A., Mehta‐Shah, N., Khodadoust, M. S., Mehta, A., Dereure, O., Battistella, M., Gru, A., Moins‐Teisserenc, H., Viotti, J., Paiva, C., Boyer‐Chammard, A., Porcu, P.

Get full text

PHASE I/II CLINICAL TRIAL OF AN ACTIVATED WHOLE TUMOR CELL VACCINE FOLLOWED BY TRANSFER OF IMMUNE T CELLS IN PATIENTS WITH MANTLE CELL LYMPHOMA by Frank, M., Khodadoust, M., Chu, M., Kohrt, H., Advani, R., Alizadeh, A., Reddy, S., Maeda, L., Gupta, N., Laport, G., Meyer, E., Miklos, D., Negrin, R., Rezvani, A., Weng, W., Sheehan, K., Czerwinski, D., Faham, M., Okada, A., Moore, H., Phillips, D., Wapnir, I., Brody, J., Levy, R.

Get full text

Phase I Study of IPH4102, Anti‐KIR3DL2 Mab, in Relapsed/Refractory Cutaneous T‐Cell Lymphomas (CTCL): Dose‐escalation Safety, Biomarker and Clinical Activity Results by Bagot, M., Porcu, P., Ram‐Wolff, C., Khodadoust, M., Basem, W., Battistella, M., Marie‐Cardine, A., Vermeer, M., Mathieu, S., Whittaker, S., Duvic, M., Bensussan, A., Paturel, C., Bonnafous, C., Thonnart, N., Widemann, A., Bonin, C., Sicard, H., Paiva, C., Pilz, K., Kim, Y.H.

Get full text

S262: THE COBALT‐LYM STUDY OF CTX130: A PHASE 1 DOSE ESCALATION STUDY OF CD70‐TARGETED ALLOGENEIC CRISPR‐CAS9–ENGINEERED CAR T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) T‐CELL MALIGNANCIES by Iyer, S. P., Sica, R. A., Ho, P. J., Hu, B., Zain, J., Prica, A., Weng, W.‐K., Kim, Y. H., Khodadoust, M. S., Palomba, M. L, Foss, F. M., Tipton, K., Cullingford, E. L., He, Q., Sharma, A., Horwitz, S. M.

Get full text

A-227 Improved detection of molecular disease using a personalized cell-free DNA assay in patients with cutaneous T-cell lymphoma by Torres, A. Bastidas, Bandali, T., Kwang, A., Duran, G., Kurtz, D., Kim, Y., Khodadoust, M.

Get full text

110 Multiparameter tissue imaging reveals the cutaneous T cell lymphoma microenvironment in response to immunotherapy by Phillips, D., Schuerch, C., Khodadoust, M., Kim, Y., Nolan, G.

Get full text

Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28 by Murray, A G, Khodadoust, M M, Pober, J S, Bothwell, A L

“…We examined the human xenoresponse to cultured porcine aortic endothelial cells (PAECs). Human CD8+ T cells proliferate to resting MHC class I-positive PAECs…”
Get more information

Redefining priorities in gene-based drug discovery by Khodadoust, M M, Klein, T P

Get full text